Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Transalta (TAC) EBITDA (2016 - 2026)

Transalta filings provide 18 years of EBITDA readings, the most recent being $67.1 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 3.74% to $67.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $95.3 million, a 62.91% decrease, with the full-year FY2025 number at $100.4 million, down 91.99% from a year prior.
  • EBITDA hit $67.1 million in Q1 2026 for Transalta, up from $22.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $541.0 million in Q4 2022 to a low of -$2.0 million in Q2 2025.
  • Median EBITDA over the past 5 years was $67.1 million (2026), compared with a mean of $120.0 million.
  • Biggest five-year swings in EBITDA: skyrocketed 65621163.65% in 2024 and later plummeted 101.72% in 2025.
  • Transalta's EBITDA stood at $541.0 million in 2022, then tumbled by 97.15% to $15.4 million in 2023, then plummeted by 72.16% to $4.3 million in 2024, then surged by 417.56% to $22.2 million in 2025, then surged by 201.79% to $67.1 million in 2026.
  • The last three reported values for EBITDA were $67.1 million (Q1 2026), $22.2 million (Q4 2025), and $8.0 million (Q3 2025) per Business Quant data.